Pineda M, Moghadam F, Ebrahimkhani MR, Kiani S.Engineered CRISPR Systems for Next Generation Gene Therapies.ACS Synth Biol. 2017 Sep 15;6(9):1614-1626.

JE Chapman, D Gillum, S Kiani.Approaches to Reduce CRISPR Off-Target Effects for Safer Genome Editing.Applied Biosafety, 1535676017694148

Guye P*, Ebrahimkhani MR*, Kipniss N, Velazquez JJ, Schoenfeld E, Kiani S, Griffith L, Weiss R.Genetically engineering self-organization of human pluripotent stem cells into a liver bud-like tissue using Gata6. Revision submitted to Nat. Communications. (* co-first authors)

Kiani S*, Chavez A*, Tuttle M, Hall RN, Chari R, Ter-Ovanesyan D, Qian J, Pruitt BW, Beal J, Vora S, Buchthal J, Kowal EJ, Ebrahimkhani MR, Collins JJ, Weiss R, Church G. Cas9 gRNA engineering for genome editing, activation and repression. Nat Methods. 2015 Sep 7. doi: 10.1038 (* co-first authors)

Chavez A*, Scheiman J*, Vora S*, Pruitt BW, Tuttle M, P R Iyer E, Lin S, Kiani S, Guzman CD, Wiegand DJ, Ter-Ovanesyan D, Braff JL, Davidsohn N, Housden BE, Perrimon N, Weiss R, Aach J, Collins JJ, Church GM. Highly efficient Cas9-mediated transcriptional programming. Nat Methods. 2015 Apr;12(4):326-8. doi: 10.1038 (* co-first authors)

Davidsohn N, Beal J, Kiani S, Adler A, Yaman F, Li Y, Xie Z, Weiss R. Accurate predictions of genetic circuit behavior from part characterization and modular composition. ACS Synth Biol. 2015 Jun 19;4(6):673-81. doi: 10.1021

Forster F, Chiba K, Schaeffer L, Regalado SG, Lai CS, Gao Q, Kiani S, Farin HF, Clevers H, Cost GC, Urnov FD, Gregory PD, Pachter L, Jaenisch R, Hockemeyer D. Human intestinal tissue with adult stem cell properties derived from pluripotent stem cells. Stem Cell Reports. 2014 Jun 3;2(6):838-52. doi: 10.1016

Kiani S, Beal J, Ebrahimkhani MR, Huh J, Hall RN, Xie Z, Li Y, Weiss R. CRISPR transcriptional repression devices and layered circuits in mammalian cells. Nat Methods. 2014 Jul;11(7):723-6. doi: 10.1038

Hockemeyer D, Wang H, Kiani S, Lai CS, Cost GC, Zhang L, Santiago Y, Miller JC, Orlando SJ, Lam S, Vincent AV, Hinkley SJ, Rebar EJ, Gregory PD, Urnov FD, JaenischR. Genetic engineering of human ES and iPS cells using TALE nucleases. Nat Biotechnol. 2011 Jul 7;29(8):731-4. doi: 10.1038

Kiani S, Valizadeh B, Hormazdi B; Samadi H; Najafi T, Samini M, Dehpour AR. Alteration in male reproductive system in experimental cholestasis: Roles for opioids and nitric oxide overproduction. Eur J Pharmacol. 2009 May 13.

Ebrahimkhani MR, Moezi L, Kiani S, Merat S, Dehpour AR. Opioid receptor blockade improves mesenteric responsiveness in biliary cirrhosis. Dig Dis Sci. 2008 Nov;53(11):3007-11.

Kiani S*, Ebrahimkhani MR*, Shariftabrizi A, Doratotaj B, Payabvash S, Riazi K, Dehghani M, Honar H, Karoon A, Amanlou M, Tavangar SM, Dehpour AR. Opioid system blockade decreases collagenase activity and improves liver injury in a rat model of cholestasis. J Gastroenterol Hepatol. 2007 Mar;22(3):406-13. (* co-first authors)

Naraghi M, Deroee AF, Ebrahimkhani M, Kiani S, Dehpour A. Nitric oxide: a new concept in chronic sinusitis pathogenesis. Am J Otolaryngol. 2007 Sep-Oct;28(5):334-7.

Ebrahimkhani MR, Kiani S, Oakley F, Kendall T, Shariftabrizi A, Tavangar SM, Moezi L, Payabvash S, Karoon A, Hoseininik H, Mann DA, Moore KP, Mani AR, Dehpour AR.
 Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats. Gut. 2006 Nov;55(11):1606-16.

Ebrahimkhani MR, Sadeghipour H, Dehghani M, Kiani S, Payabvash S, Riazi K, Honar H, Pasalar P, Mirazi N, Amanlou M, Farsam H, Dehpour AR. Homocysteine alterations in experimental cholestasis and its subsequent cirrhosis. 
Life Sci. 2005 Apr 8;76(21):2497-512.

Riazi K, Honar H, Homayoun H, Rashidi N, Kiani S, Ebrahimkhani MR, Noorian AR, Ghaffari K, Jannati A, Dehpour AR. The synergistic anticonvulsant effect of agmatine and morphine: possible role of alpha 2-adrenoceptors. Epilepsy Res. 2005 Jun;65(1-2):33-40.